[Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].
Albuminopoyesis, prothrombin activity, BSF clearance, bioptic and sometimes also laparoscopic pictures have been examined in order to test the hepatic activity of SAMe. This study has been carried out in patients suffering from liver cirrhosis and other chronic hepatites. The above-mentioned parameters proved to be significantly improved in almost all the 25 patients studied and checked after 30 and 60 days' treatment with 30-45 mg SAMe administered by slow intravenous route.
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005234:Fatty Liver / Q000188:drug therapy; D005260:Female; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007565:Jaundice / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012436:S-Adenosylmethionine / Q000627:therapeutic use*
D012436:S-Adenosylmethionine
Attività terapeutiche della solfo-adenosilmetionina in alcune epatopatie croniche